Author: OurCrowd

[PRESS RELEASE] OURCROWD LEADS $12M INVESTMENT IN ISRAELI COVID-19 VACCINE COMPANY MIGVAX

Kiryat Shemona, Israel, April 22, 2020 –  OurCrowd, the world’s largest crowdfunding venture investment platform, based in Jerusalem, today announced that it would lead a $12 million investment in the newly formed MigVax Corp., which will develop a novel COVID-19 vaccine. MigVax, an affiliate of The Migal Galilee Research Institute, is pioneering the effort to develop Israel’s human vaccine against COVID-19. Read more...

Read More